Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Sep 24;322(12):1212-1213.
doi: 10.1001/jama.2019.11148.

Measuring the Quality of Diabetes Care-Reply

Rozalina G McCoy  1 , Rene Rodriguez-Gutierrez  2
Affiliations
Comment

Measuring the Quality of Diabetes Care-Reply

Rozalina G McCoy et al. JAMA. .
No abstract available

PubMed Disclaimer

Comment on

  • Measuring the Quality of Diabetes Care.
    Giugliano D, Maiorino MI, Esposito K. Giugliano D, et al. JAMA. 2019 Sep 24;322(12):1212. doi: 10.1001/jama.2019.11136. JAMA. 2019. PMID: 31550021 No abstract available.

References

    1. Rodriguez Gutierrez R, McCoy RG. Measuring what matters in diabetes. JAMA. 2019;321(19):1865–1866. doi=10.1001/jama.2019.4310 - DOI - PMC - PubMed
    1. Rodríguez Gutiérrez R, Montori VM. Glycemic control for patients with type 2 diabetes mellitus: our evolving faith in the face of evidence. Circ Cardiovasc Qual Outcomes. 2016;9(5):504–512. doi/10.1161/CIRCOUTCOMES.116.002901 - DOI - PMC - PubMed
    1. Coca SG, Ismail Beigi F, Haq N, Krumholz HM, Parikh CR. Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus. Arch Intern Med. 2012;172(10):761–769. doi=10.1001/archinternmed.2011.2230 - DOI - PMC - PubMed
    1. Boussageon R, Bejan Angoulvant T, Saadatian Elahi M, et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ. 2011;343(jul26 1):d4169–d4169. doi/10.1136/bmj.d4169 - DOI - PMC - PubMed
    1. Cefalu WT, Kaul S, Gerstein HC, et al. Cardiovascular outcomes trials in type 2 diabetes: where do we go from here? Reflections from a Diabetes Care editors’ expert forum. Diabetes Care. 2018;41(1):14–31. doi/10.2337/dci17-0057 - DOI - PMC - PubMed